ClassID:

95301

C07D417/12 - page 7 - CPC Classification

Classification description:

Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group containing two hetero rings linked by a chain containing hetero atoms as chain links

Recent Application in this class:
#1801
20190008866
2019-01-10

BROMODOMAIN INHIBITORS

#1802
20190008842
2019-01-10

Deuterium-enriched pioglitazone

#1803
20190002477
2019-01-03

ANTI-VIRAL COMPOUNDS, PHARMACEUTICAL COMPOSITIONS, AND METHODS OF USE THEREOF

#1804
20190002472
2019-01-03

Immunoregulatory agents

#1805
20190002420
2019-01-03

PROCESS AND INTERMEDIATES FOR PREPARATION OF THIAZINE DERIVATIVES

#1806
20190000858
2019-01-03

Inhibitors of -linked glycosylation and methods using same

#1807
20190000856
2019-01-03

MTH1 inhibitors for treatment of inflammatory and autoimmune conditions

#1808
20190000844
2019-01-03

Methods for treating Huntington's disease

#1809
20190000832
2019-01-03

Tetrahydroisoquinolin-1-one derivative or salt thereof

#1810
20190000823
2019-01-03

2-amino-6-(difluoromethyl)-5,5-difluoro-6-phenyl-3,4,5,6-tetrahydropyridines as BACE1 inhibitors

#1811
20180370974
2018-12-27

Compounds and their use as inhibitors of N-myristoyl transferase

#1812
20180370966
2018-12-27

METHODS OF TREATMENT USING PYRIDINONYL PDK1 INHIBITORS

#1813
20180370933
2018-12-27

Compounds and compositions for inhibition of FASN

#1814
20180370930
2018-12-27

Glutaminase inhibitors and method of use

#1815
20180369226
2018-12-27

Alkynyl dihydroquinoline sulfonamide compounds

#1816
20180364220
2018-12-20

Flavors, flavor modifiers, tastants, taste enhancers, umami or sweet tastants, and/or enhancers and use thereof

#1817
20180362520
2018-12-20

Inhibitors of LC3/Atg3 interaction and their use in the treatment of cancer

#1818
20180362519
2018-12-20

Tubulysin analogs and methods for their preparation

#1819
20180362518
2018-12-20

Diamino-alkylamino-linked arylsulfonamide compounds with selective activity in voltage-gated sodium channels

#1820
20180362483
2018-12-20

Inhibitors of cyclin-dependent kinases

#1821
20180362475
2018-12-20

Spiropyrazine derivatives as inhibitors of non-apoptotic regulated cell-death

#1822
20180362461
2018-12-20

Pyrrolidine derivatives

#1823
20180362460
2018-12-20

Cyanopyrrolidine derivatives as inhibitors for DUBs

#1824
20180361426
2018-12-20

Display inserts, overlays, and graphical user interfaces for multimedia systems

#1825
20180360046
2018-12-20

Benzamide compounds and their use as herbicides

#1826
20180354943
2018-12-13

C5-C6-carbocyclic fused iminothiadiazine dioxides as BACE inhibitors, compositions, and their use

#1827
20180354908
2018-12-13

Pharmaceutical compound

#1828
20180354906
2018-12-13

Human plasma kallikrein inhibitors

#1829
20180354902
2018-12-13

(Hetero)aryl cyclopropylamine compounds as LSD1 inhibitors

#1830
20180346461
2018-12-06

COMPOUNDS AND METHODS FOR THE TARGETED DEGRADATION OF ANDROGEN RECEPTOR

#1831
20180346460
2018-12-06

Inhibitors of lysine gingipain

#1832
20180346459
2018-12-06

Substituted benzenesulfonamides as sodium channel blockers

#1833
20180346423
2018-12-06

Pyridine compounds as fungicides

#1834
20180339982
2018-11-29

Bicyclic heterocyclic derivatives as bromodomain inhibitors

#1835
20180339970
2018-11-29

Pyrazole MAGL inhibitors

#1836
20180338972
2018-11-29

Anthelmintic compounds

#1837
20180338970
2018-11-29

Pyruvate kinase activators for use in therapy

#1838
20180338957
2018-11-29

Antimicrobial agents

#1839
20180334454
2018-11-22

KRAS G12C inhibitors and methods of using the same

#1840
20180334451
2018-11-22

Substituted 1,2,3-triazoles as NR2B-selective NMDA modulators

#1841
20180334441
2018-11-22

MITOTIC KINESIN INHIBITORS AND METHODS OF USE THEREOF

#1842
20180334440
2018-11-22

Inhibitors of arginine gingipain

#1843
20180334439
2018-11-22

Antimicrobial Compounds And Methods Of Making And Using The Same

#1844
20180334438
2018-11-22

PYRAZOLYL GUANIDINE F1F0-ATPASE INHIBITORS AND THERAPEUTIC USES THEREOF

#1845
20180334435
2018-11-22

6-HETEROARYLOXY- OR 6-ARYLOXY-QUINOLINE-2-CARBOXAMIDES AND METHOD OF USE

#1846
20180333746
2018-11-22

Display inserts, overlays, and graphical user interfaces for multimedia systems

#1847
20180327416
2018-11-15

Pyrazole compounds and methods of making and using same

#1848
20180327398
2018-11-15

Pesticidally active amide heterocyclic derivatives with sulphur containing substituents

#1849
20180327397
2018-11-15

Lactam compound derivative and application thereof

#1850
20180327381
2018-11-15

Aryl cyclopropyl-amino-isoquinolinyl amide compounds

#1851
20180327360
2018-11-15

NOVEL PYRIDINE DERIVATIVES

#1852
20180327358
2018-11-15

Piperidinone formyl peptide 2 receptor and formyl peptide 1 receptor agonists

#1853
20180319784
2018-11-08

Phenylthiazoles and uses thereof

#1854
20180319783
2018-11-08

Ferroportin inhibitors

#1855
20180319779
2018-11-08

Substituted benzofuranyl and benzoxazolyl compounds and uses thereof

#1856
20180319764
2018-11-08

Tricyclic spiro compound

#1857
20180319755
2018-11-08

Polymerizable compound and optically anisotropic body

#1858
20180318310
2018-11-08

Modulators of HEC1 activity and methods therefor

#1859
20180318309
2018-11-08

Aryl-or heteroaryl-substituted benzene compounds

#1860
20180318266
2018-11-08

Isoxazoline-substituted benzamide compound and pesticide

#1861
20180317488
2018-11-08

Use of Substituted Oxadiazoles for Combating Phytopathogenic Fungi

#1862
20180312530
2018-11-01

PROCESSES FOR MAKING ALKYLATED ARYLPIPERAZINE AND ALKYLATED ARYLPIPERIDINE COMPOUNDS INCLUDING NOVEL INTERMEDIATES

#1863
20180312503
2018-11-01

Nitrogen-containing aromatic heterocyclic compound

#1864
20180312500
2018-11-01

ANTI-ALPHAVBETA1 INTEGRIN COMPOUNDS AND METHODS

#1865
20180312498
2018-11-01

Propionic acid derivatives and methods of use thereof

#1866
20180312481
2018-11-01

Polymerizable compound and optically anisotropic body

#1867
20180312477
2018-11-01

Substituted thiazoles for preventing and/or treating cell or tissue necrosis

#1868
20180312470
2018-11-01

Derivatives of halo quinabactin

#1869
20180311254
2018-11-01

DNA-PK INHIBITORS

#1870
20180305403
2018-10-25

PPAR agonists and methods of use thereof

#1871
20180305360
2018-10-25

COMT inhibiting methods and compositions

#1872
20180305347
2018-10-25

METHODS AND COMPOSITIONS USEFUL IN TREATING CANCER AND REDUCING WNT MEDIATED EFFECTS IN A CELL

#1873
20180305316
2018-10-25

Compounds, compositions and methods

#1874
20180305312
2018-10-25

EBNA1 inhibitors and methods using same

#1875
20180303831
2018-10-25

2,3-disubstituted 1-acyl-4-amino-1,2,3,4-tetrahydroquinoline derivatives and their use as bromodomain inhibitors

#1876
20180298054
2018-10-18

Targeted nitroxide agents

#1877
20180298043
2018-10-18

Alkyne Compounds for Treatment of Complement Mediated Disorders

#1878
20180298031
2018-10-18

Heterocycle amines and uses thereof

#1879
20180298010
2018-10-18

PRMT5 INHIBITORS AND USES THEREOF

#1880
20180297991
2018-10-18

Ferroportin inhibitors

#1881
20180297964
2018-10-18

Compounds as inhibitors of the YAP/TAZ-TEAD interaction and their use in the treatment of malignant mesothelioma

#1882
20180297954
2018-10-18

2,4-dihydroxy-nicotinamides as APJ agonists

#1883
20180297948
2018-10-18

Sodium channel blockers

#1884
20180297939
2018-10-18

Alpha-cinnamide compounds and compositions as HDAC8 inhibitors

#1885
20180291047
2018-10-11

ALKYNE COMPOUNDS FOR TREATMENT OF COMPLEMENT MEDIATED DISORDERS

#1886
20180291046
2018-10-11

ALKYNE COMPOUNDS FOR TREATMENT OF COMPLEMENT MEDIATED DISORDERS

#1887
20180291035
2018-10-11

MYC MODULATORS AND USES THEREOF

#1888
20180291015
2018-10-11

Substituted fused imidazole derivatives, pharmaceutical compositions, and methods of use thereof

#1889
20180291014
2018-10-11

Therapeutic compounds and methods of use thereof

#1890
20180291013
2018-10-11

COMPOSITIONS AND METHODS FOR THE TREATMENT OF METABOLIC AND RELATED DISORDERS

#1891
20180290988
2018-10-11

Modulators of indoleamine 2,3-dioxygenase

#1892
20180290978
2018-10-11

Monocarboxylate transport modulators and uses thereof

#1893
20180290975
2018-10-11

Inhibitors of EGFR and methods of use thereof

#1894
20180290974
2018-10-11

Urea derivative or pharmacologically acceptable salt thereof

#1895
20180289704
2018-10-11

Compounds useful as modulators of TRPM8

#1896
20180282341
2018-10-04

3-(CARBOXYMETHYL)-8-AMINO-2-OXO-1,3-DIAZA-SPIRO-[4.5]-DECANE DERIVATIVES

#1897
20180282308
2018-10-04

Inhibitors of KRAS G12C mutant proteins

#1898
20180282307
2018-10-04

Inhibitors of KRAS G12C mutant proteins

#1899
20180282272
2018-10-04

SUBSTITUTED HETEROCYCLIC SULFONAMIDE COMPOUNDS USEFUL AS TRPA1 MODULATORS

#1900
20180277762
2018-09-27

Amine compound and organic light-emitting device comprising same

#1901
20180273521
2018-09-27

Hepatitis B core protein allosteric modulators

#1902
20180273520
2018-09-27

Hepatitis B core protein modulators

#1903
20180273494
2018-09-27

Microbiocidal oxadiazole derivatives

#1904
20180271846
2018-09-27

Five-membered heterocyclic amides WNT pathway inhibitor

#1905
20180271824
2018-09-27

N4-phenyl-quinazoline-4-amine derivatives and related compounds as ErbB type I receptor tyrosine kinase inhibitors for the treatment of hyperproliferative diseases

#1906
20180265523
2018-09-20

Antibacterial therapeutics and prophylactics

#1907
20180265518
2018-09-20

Apelin receptor (APJ) agonists and uses thereof

#1908
20180265504
2018-09-20

Amide-substituted heterocyclic compounds useful as modulators of IL-12, IL-23 and/or IFN alpha responses

#1909
20180265502
2018-09-20

Tetrahydroquinoline sulfonamide and related compounds for use as agonists of RORγ and the treatment of disease

#1910
20180265484
2018-09-20

Hepatitis B core protein modulators

#1911
20180263963
2018-09-20

Modulators of the adenosine A3 receptors

#1912
20180258084
2018-09-13

Hepatitis B core protein modulators

#1913
20180258083
2018-09-13

INHIBITORS OF LRRK2 KINASE ACTIVITY

#1914
20180258062
2018-09-13

Halogen-substituted heterocyclic compound

#1915
20180258056
2018-09-13

AMINO QUINAZOLINES AS KINASE INHIBITORS

#1916
20180258052
2018-09-13

5-[(piperazin-1-yl)-3-oxo-propyl]-imidazolidine-2,4-dione derivatives as ADAMTS inhibitors for the treatment of osteoarthritis

#1917
20180258049
2018-09-13

Human plasma kallikrein inhibitors

#1918
20180258043
2018-09-13

PYRIDYL INHIBITORS OF HEDGEHOG SIGNALLING

#1919
20180258038
2018-09-13

N,N-SUBSTITUTED 3-AMINOPYRROLIDINE COMPOUNDS USEFUL AS MONOAMINES REUPTAKE INHIBITORS

#1920
20180256586
2018-09-13

Compounds and methods for the targeted degradation of fetal liver kinase polypeptides

#1921
20180251475
2018-09-06

Heterocyclic compounds and uses thereof

#1922
20180251458
2018-09-06

Histone demethylase inhibitors

#1923
20180251457
2018-09-06

COMPOSITIONS, FORMULATIONS AND METHODS FOR TREATING OCULAR DISEASES

#1924
20180251437
2018-09-06

1,3,4-oxadiazole sulfonamide derivative compounds as histone deacetylase 6 inhibitor, and the pharmaceutical composition comprising the same

#1925
20180251436
2018-09-06

Certain (2S)-N-[(1S)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides as dipeptidyl peptidase 1 inhibitors

#1926
20180251431
2018-09-06

1,3-SUBSTITUTED PYRAZOLE COMPOUNDS USEFUL FOR REDUCTION OF VERY LONG CHAIN FATTY ACID LEVELS

#1927
20180251429
2018-09-06

Farnesoid X receptor agonists and uses thereof

#1928
20180251426
2018-09-06

APOPTOSIS-INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE AND AUTOIMMUNE DISEASES

#1929
20180244666
2018-08-30

Dual mechanism inhibitors for the treatment of disease

#1930
20180244632
2018-08-30

HIV replication inhibiting pyrimidines

#1931
20180238863
2018-08-23

CHEMICAL SYNTHESIS

#1932
20180237439
2018-08-23

Pyrazole derivatives useful as 5-lipoxygenase activating protein (FLAP) inhibitors

#1933
20180237431
2018-08-23

COMPOSITIONS, FORMULATIONS AND METHODS FOR TREATING OCULAR DISEASES

#1934
20180237430
2018-08-23

COMPOSITIONS, FORMULATIONS AND METHODS FOR TREATING OCULAR DISEASES

#1935
20180237429
2018-08-23

COMPOSITIONS, FORMULATIONS AND METHODS FOR TREATING OCULAR DISEASES

#1936
20180237428
2018-08-23

Compounds as ROR gamma modulators

#1937
20180237418
2018-08-23

Modulators of estrogen receptor proteolysis and associated methods of use

#1938
20180235226
2018-08-23

Azoline compounds

#1939
20180230115
2018-08-16

cGAS antagonist compounds

#1940
20180230114
2018-08-16

1,3,4-oxadiazole derivative compounds as histone deacetylase 6 inhibitor, and the pharmaceutical composition comprising the same

#1941
20180230085
2018-08-16

1,4-disubstituted imidazole derivative

#1942
20180222899
2018-08-09

Bis-heteroaryl derivatives as modulators of protein aggregation

#1943
20180222898
2018-08-09

Modulators of calcium release-activated calcium channel

#1944
20180222883
2018-08-09

Heterocyclic compounds useful as modulators of TNF alpha

#1945
20180222874
2018-08-09

Modulators of myocyte lipid accumulation and insulin resistance and methods of use thereof

#1946
20180222858
2018-08-09

DERIVATIVES OF DOLASTATIN 10 AND AURISTATINS

#1947
20180215757
2018-08-02

Compounds and methods for inhibiting fascin

#1948
20180215749
2018-08-02

Dual mechanism inhibitors for the treatment of disease

#1949
20180215741
2018-08-02

1-(arylmethyl)quinazoline-2,4(1H,3H)-diones as PARP inhibitors and the use thereof

#1950
20180215740
2018-08-02

PARA-SUBSTITUTED INDANYL AND TETRALINYL DERIVATIVES

#1951
20180215739
2018-08-02

2-(1-heteroarylpiperazin-4-yl)methyl-1,4-benzodioxane derivatives as alpha2C antagonists

#1952
20180213782
2018-08-02

Heterocyclic compounds as pesticides

#1953
20180208590
2018-07-26

Compounds having estrogen receptor alpha degradation activity and uses thereof

#1954
20180208589
2018-07-26

LMP7 inhibitors

#1955
20180208587
2018-07-26

Tetrahydroquinoline sulfonamide and related compounds for use as agonists of RORγ and the treatment of disease

#1956
20180208575
2018-07-26

TRPV1 antagonists including dihydroxy substituent and uses thereof

#1957
20180208552
2018-07-26

Urea derivative or pharmacologically acceptable salt thereof

#1958
20180207144
2018-07-26

Enhancer of Zeste Homolog 2 inhibitors

#1959
20180206498
2018-07-26

SUBSTITUTED HETEROARYL CARBOXYLIC ACID HYDRAZIDES OR SALTS THEREOF AND USE THEREOF TO INCREASE STRESS TOLERANCE IN PLANTS

#1960
20180206497
2018-07-26

Aryloxypyrimidinyl ethers as herbicides

#1961
20180206491
2018-07-26

SUBSTITUTED CYCLIC ARYL AND HETEROARYL CARBOXYLIC ACID HYDRAZIDES OR SALTS THEREOF AND USE THEREOF TO INCREASE STRESS TOLERANCE IN PLANTS

#1962
20180201592
2018-07-19

2-AMINO-1,3,4-THIADIAZINE AND 2-AMINO-1,3,4-OXADIAZINE BASED ANTIFUNGAL AGENTS

#1963
20180201588
2018-07-19

Phenoxymethyl derivatives

#1964
20180201582
2018-07-19

S1P3 ANTAGONISTS

#1965
20180200229
2018-07-19

Triazolone compounds as MPGES-1 inhibitors

#1966
20180194767
2018-07-12

5-aromatic alkynyl substituted benzamide compound and preparation method, pharmaceutical composition, and use thereof

#1967
20180194759
2018-07-12

NOVEL FORMULATION OF MELOXICAM

#1968
20180194731
2018-07-12

THERAPEUTIC COMPOUNDS

#1969
20180194724
2018-07-12

Cyanopyrrolidines as dub inhibitors for the treatment of cancer

#1970
20180193315
2018-07-12

SPIROCYCLIC HAT INHIBITORS AND METHODS FOR THEIR USE

#1971
20180192650
2018-07-12

N-(tetrazol-5-yl)- and N-(triazol-5-yl)arylcarboxamide derivatives with herbicidal action

#1972
20180186798
2018-07-05

PRMT5 INHIBITORS AND USES THEREOF

#1973
20180186784
2018-07-05

Crystalline forms of N-(2-chloro-6-methy]phenvn-2-[F6-[4-(2-hvdroxvethvl)-L-piperazin-vil-2-methvil-4-pvrimidinvllaminol-5-thiazolecarboxamide and their process thereof

#1974
20180186783
2018-07-05

Inhibitors of protein kinases

#1975
20180186746
2018-07-05

6-aminoisoquinoline compounds

#1976
20180185364
2018-07-05

Modulators of cystic fibrosis transmembrane conductance regulator

#1977
20180185363
2018-07-05

Phthalazinone derivatives

#1978
20180179225
2018-06-28

ANTIMICROBIAL AGENTS

#1979
20180179194
2018-06-28

NADPH oxidase 4 inhibitors

#1980
20180179188
2018-06-28

Substituted piperazine compounds and methods of use and use thereof

#1981
20180179171
2018-06-28

N-(1,3,4-oxadiazol-2-yl)aryl carboxamide derivatives with herbicidal action

#1982
20180179159
2018-06-28

1,4-substituted piperidine derivatives

#1983
20180179158
2018-06-28

Efflux-pump inhibitors and therapeutic uses thereof

#1984
20180170929
2018-06-21

Pyrimidine-2,4-diamine derivatives for treatment of cancer

#1985
20180170924
2018-06-21

PI-kinase inhibitors with anti-infective activity

#1986
20180170922
2018-06-21

Substituted pyrazines as ATR kinase inhibitors

#1987
20180170898
2018-06-21

Beta- and gamma-amino-isoquinoline amide compounds and substituted benzamide compounds

#1988
20180170889
2018-06-21

Simplified structural mimetics of AIPS as quorum sensing inhibitors

#1989
20180170888
2018-06-21

Bicyclic tetrahydrothiazepine derivatives useful for the treatment of neoplastic and/or infectious diseases

#1990
20180170887
2018-06-21

Heteroaryl butanoic acid derivatives

#1991
20180170883
2018-06-21

Hsp70 modulators and methods for making and using the same

#1992
20180170879
2018-06-21

Pyrazole derivative or pharmaceutically acceptable salt thereof

#1993
20180170876
2018-06-21

Histone deacetylase inhibitors

#1994
20180170874
2018-06-21

Heterocyclic compound

#1995
20180170863
2018-06-21

ROR gamma (RORγ) modulators

#1996
20180170857
2018-06-21

PPAR agonists

#1997
20180169063
2018-06-21

Benzothiophene derivatives and compositions thereof as selective estrogen receptor degraders

#1998
20180162868
2018-06-14

BENZENESULFONAMIDE COMPOUNDS AND THEIR USE AS THERAPEUTIC AGENTS

#1999
20180162853
2018-06-14

Cyclopropanamine compound and use thereof

#2000
20180162852
2018-06-14

Compounds

#2001
20180162847
2018-06-14

PRMT5 INHIBITORS CONTAINING A DIHYDRO- OR TETRAHYDROISOQUINOLINE AND USES THEREOF

#2002
20180162823
2018-06-14

Phthalazinones and isoquinolinones as rock inhibitors

#2003
20180162816
2018-06-14

Heterocyclic compounds for the treatment of neurological and psychological disorders

#2004
20180161336
2018-06-14

DNA-PK inhibitors

#2005
20180161322
2018-06-14

PHARMACEUTICAL COMPOSITION

#2006
20180161313
2018-06-14

Inhibitors of Mc1-1 as drugs to overcome resistance to BRAF inhibitors and MEK inhibitors

#2007
20180155336
2018-06-07

PROCESS FOR THE PREPARATION OF 2-{4-[2-({[2-(4-CHLOROPHENYL)-1,3-THIAZOL-4-YL]METHYL}SULFANYL)-3,5-DICYAN0-6-(PYRROLIDIN-1-YL)PYRIDIN-4-YL]PHENOXY}ETHYL-L-ALANYL-L-ALANINATE MONOHYDROCHLORIDE

#2008
20180155303
2018-06-07

Ribonucleotide reductase inhibitors and methods of use

#2009
20180155301
2018-06-07

ISOXAZOLINE COMPOSITIONS AND THEIR USE AS ANTIPARASITICS

#2010
20180155296
2018-06-07

SPIROCYCLOHEPTANES AS INHIBITORS OF ROCK

#2011
20180155289
2018-06-07

Mixed disulfide conjugates of thienopyridine compounds and uses thereof

#2012
20180155283
2018-06-07

Dopamine D2 receptor ligands

#2013
20180148440
2018-05-31

SUBSTITUTED 2-(CHROMAN-6-YLOXYL)-THIAZOLES AND THEIR USE AS PHARMACEUTICALS

#2014
20180148439
2018-05-31

Deuterated O-sulfated beta lactam hydroxamic acids and deuterated N-sulfated beta lactams

#2015
20180148418
2018-05-31

AMIDO-SUBSTITUTED CYCLOHEXANE DERIVATIVES

#2016
20180141923
2018-05-24

Substituted piperazines as selective HDAC1,2 inhibitors

#2017
20180141919
2018-05-24

DIAMINOPYRIMIDINES AS P2X3 AND P2X2/3 ANTAGONISTS

#2018
20180141910
2018-05-24

Fused-bicyclic aryl quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors

#2019
20180133348
2018-05-17

Nuclear imaging and radiotherapeutics agents targeting carbonic anhydrase IX and uses thereof

#2020
20180133204
2018-05-17

5-deutero-2,4-thiazolidinedione derivatives and compositions comprising and methods of using the same

#2021
20180133202
2018-05-17

2,4-thiazolidinedione derivatives in the treatment of central nervous system disorders

#2022
20180127712
2018-05-10

Methods of enhancing cell survival of stem cells

#2023
20180127463
2018-05-10

Desacetoxytubulysin H and analogs thereof

#2024
20180127432
2018-05-10

Bicyclic-fused heteroaryl or aryl compounds

#2025
20180127407
2018-05-10

Benzothiazole or benzoxazole compounds as SUMO activators

#2026
20180127406
2018-05-10

Arylcyclopropylamine based demethylase inhibitors of LSD1 and their medical use

#2027
20180127405
2018-05-10

COMPOUNDS

#2028
20180127400
2018-05-10

Compounds, compositions, and methods for increasing CFTR activity

#2029
20180127375
2018-05-10

Morphinan derivatives for the treatment of neuropathic pain

#2030
20180127369
2018-05-10

LSD1 inhibitors

#2031
20180127356
2018-05-10

Phenyl and pyridinyl hydroxamic acids

#2032
20180126414
2018-05-10

Display inserts, overlays, and graphical user interfaces for multimedia systems

#2033
20180125848
2018-05-10

PREPARATION AND METHODS OF USE FOR ORTHO-ARYL 5-MEMBERED HETEROARYL-CARBOXAMIDE CONTAINING MULTI-TARGETED KINASE INHIBITORS

#2034
20180125827
2018-05-10

5-DEUTERO-THIAZOLIDINE-2,4-DIONE COMPOUNDS AND METHODS OF TREATING MEDICAL DISORDERS USING SAME

#2035
20180125072
2018-05-10

Molecules having certain pesticidal utilities, and intermediates, compositions, and processes related thereto

#2036
20180123819
2018-05-03

Display inserts, overlays, and graphical user interfaces for multimedia systems

#2037
20180120306
2018-05-03

Haptens, hapten conjugates, compositions thereof and method for their preparation and use

#2038
20180118748
2018-05-03

Compounds for improving mRNA splicing

#2039
20180118735
2018-05-03

INHIBITORS OF LEUKOTRIENE A4 HYDROLASE

#2040
20180118733
2018-05-03

1AP E3 ligase directed proteolysis targeting chimeric molecules

#2041
20180118732
2018-05-03

Quinolinone five-membered heterocyclic compounds as mutant-isocitrate dehydrogenase inhibitors

#2042
20180118731
2018-05-03

1,3-thiazol-2-yl substituted benzamides

#2043
20180118724
2018-05-03

Solid dosage formulations of substituted quinazoline receptor-type kinase modulators and methods of use thereof

#2044
20180118704
2018-05-03

Compounds for treating parasitic infections

#2045
20180118697
2018-05-03

Triazole benzamide derivatives and the compositions and methods of treatment regarding the same

#2046
20180118694
2018-05-03

6-membered heterocyclic derivatives and pharmaceutical composition comprising the same

#2047
20180118693
2018-05-03

Compounds for treatment of cancer

#2048
20180118683
2018-05-03

Indolone compounds and their use as AMPA receptor modulators

#2049
20180118680
2018-05-03

SUBSTITUTED HETEROCYCLIC SULFONAMIDE COMPOUNDS USEFUL AS TRPA1 MODULATORS

#2050
20180116221
2018-05-03

Pyridine compounds for controlling invertebrate pests II

#2051
20180116219
2018-05-03

Herbicidal compounds

#2052
20180111924
2018-04-26

Molecules having certain pesticidal utilities, and intermediates, compositions, and processes related thereto

#2053
20180110227
2018-04-26

Herbicidal compounds

#2054
20180110225
2018-04-26

Herbicidal compounds

#2055
20180105518
2018-04-19

TrkA kinase inhibitors, compositions and methods thereof

#2056
20180105516
2018-04-19

Aryl sultam derivatives as RORc modulators

#2057
20180105504
2018-04-19

Therapeutic compounds and methods of use thereof

#2058
20180099982
2018-04-12

Processes for making alkylated arylpiperazine and alkylated arylpiperidine compounds including novel intermediates

#2059
20180099981
2018-04-12

Compounds, compositions and methods

#2060
20180099960
2018-04-12

Protein kinase inhibitors

#2061
20180099959
2018-04-12

Protein kinase inhibitors

#2062
20180099958
2018-04-12

Pesticidal compositions and methods

#2063
20180099952
2018-04-12

Hepatitis B viral assembly effectors

#2064
20180099936
2018-04-12

Inhibitor compounds of phosphodiesterase type 10A

#2065
20180093980
2018-04-05

1,3-thiazol-2-yl substituted benzamides

#2066
20180093979
2018-04-05

Heteroaryl amides as inhibitors of protein aggregation

#2067
20180093978
2018-04-05

Indazolyl thiadiazolamines and related compounds for inhibition of Rho-associated protein kinase and the treatment of disease

#2068
20180093973
2018-04-05

Biaryl inhibitors of bruton's tyrosine kinase

#2069
20180092908
2018-04-05

SMALL MOLECULE OXIDIZERS OF PDI AND THEIR USE

#2070
20180092880
2018-04-05

Somatostatin receptor subtype 4 (SSTR4) agonists

#2071
20180086777
2018-03-29

Compositions of protein receptor tyrosine kinase inhibitors

#2072
20180086752
2018-03-29

Compositions and methods of targeting mutant K-RAS

#2073
20180086751
2018-03-29

SWEETENER COMPOSITION

#2074
20180086750
2018-03-29

Histone deacetylase inhibitors and their use in therapy

#2075
20180086749
2018-03-29

INHIBITORS OF VIRUSES

#2076
20180086742
2018-03-29

Substituted oxopyridine derivatives and use thereof cardiovascular disorders

#2077
20180086739
2018-03-29

PLK4 inhibitors

#2078
20180086708
2018-03-29

1-cyano-pyrrolidine compounds as USP30 inhibitors

#2079
20180086697
2018-03-29

Inhibitors of human immunodeficiency virus replication

#2080
20180085365
2018-03-29

Amino-quinolines as kinase inhibitors

#2081
20180079720
2018-03-22

Substituted 6,7-dihydro-5H-benzo[7]annulene compounds, processes for their preparation and therapeutic uses thereof

#2082
20180079712
2018-03-22

Inhibitors of indoleamine-2,3-dioxygenase for the treatment of cancer

#2083
20180072762
2018-03-15

ALKYNE COMPOUNDS FOR TREATMENT OF COMPLEMENT MEDIATED DISORDERS

#2084
20180072756
2018-03-15

Methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compounds

#2085
20180072744
2018-03-15

HETEROARYL SYK INHIBITORS

#2086
20180072713
2018-03-15

1,3-thiazol-2-yl substituted benzamides

#2087
20180072660
2018-03-15

Inhibitors of indoleamine-2,3-dioxygenase for the treatment of cancer

#2088
20180071289
2018-03-15

METHODS AND COMPOSITIONS FOR THE TREATMENT OF CANCER AND RELATED HYPERPROLIFERATIVE DISORDERS

#2089
20180071262
2018-03-15

SPIROCYCLIC HAT INHIBITORS AND METHODS FOR THEIR USE

#2090
20180071232
2018-03-15

Compositions and methods for treating respiratory injury or disease

#2091
20180065932
2018-03-08

ANTIVIRAL COMPOUNDS

#2092
20180057455
2018-03-01

Compounds useful as immunomodulators

#2093
20180051017
2018-02-22

AGENT FOR TREATMENT OF SCHIZOPHRENIA

#2094
20180050997
2018-02-22

Compounds and compositions for inhibition of FASN

#2095
20180050021
2018-02-22

Derivatives of 1-[(cyclopentyl or 2-pyrrolidinyl)carbonylaminomethyl]-4-(l,3-thiazol-5-yl) benzene which are useful for the treatment of proliferative, autoimmune or inflammatory diseases

#2096
20180049437
2018-02-22

Substituted cyclic amides as herbicides

#2097
20180044334
2018-02-15

Histone demethylase inhibitors

#2098
20180044332
2018-02-15

MOLECULES HAVING CERTAIN PESTICIDAL UTILITIES, AND INTERMEDIATES, COMPOSITIONS, AND PROCESSES RELATED THERETO

#2099
20180044290
2018-02-15

Urea derivative or pharmacologically acceptable salt thereof

#2100
20180044287
2018-02-15

Sulfonylureas and related compounds and use of same